ArticleCureus2026
Posterior Fossa Astroblastoma: A Case Report.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Astroblastoma is an extremely rare glial tumor that only rarely occurs in the posterior fossa. We report a case of posterior fossa astroblastoma in an adult patient to highlight its diagnostic challenges and management approach. A 38-year-old man presented with a two-week history of headaches and dizziness without focal neurological deficits. Cranial computed tomography (CT) and magnetic resonance imaging (MRI) revealed a well-defined 3.2 cm midline cerebellar mass containing both cystic and solid components, with a "cauliflower-like" enhancing solid portion and mild surrounding edema. The patient underwent a suboccipital craniotomy with complete microsurgical resection of the tumor, and he recovered well with no neurological deficits. Histopathology confirmed astroblastoma, showing characteristic perivascular pseudorosettes and hyalinized blood vessels. Tumor cells were immunopositive for glial fibrillary acidic protein (GFAP), epithelial membrane antigen (EMA) in a dot-like pattern, and D2-40. No high-grade features (such as increased mitotic activity, microvascular proliferation, or significant nuclear atypia) were observed, consistent with a low-grade tumor. No adjuvant therapy was administered, and at three-year follow-up, the patient remains recurrence-free. Astroblastoma in the posterior fossa is exceptionally uncommon, posing a diagnostic challenge due to its nonspecific clinical and radiologic presentation. This case underscores that definitive diagnosis requires histopathological confirmation and that complete surgical resection can achieve favorable long-term outcomes. Long-term surveillance is recommended given the potential for late recurrence.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.